Germany is suspending routine use of the Oxford-AstraZeneca Covid-19 vaccine for people aged below 60 because of a risk of rare blood clots. The German medicines regulator found 31 cases of a type of rare blood clot among the nearly … Read more →
The Chief Executive Officer (CEO) of AstraZeneca, Pascal Soriot, has expressed delight that the first doses of the vaccine produced by the Serum Institute of India has been delivered. Ghana became the first country on Wednesday, February 24 to take … Read more →